We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Center Dedicated to Cancer Molecular Imaging

By HospiMedica staff writers
Posted on 12 Oct 2006
A new center will work to improve traditional cancer-detection methods by identifying cancer-specific genes that are ideally suited for molecular imaging and diagnosis.

Case Western Reserve University School of Medicine (Cleveland, OH, USA) and the U.S. More...
National Foundation for Cancer Research (NFCR, Bethesda, MD, USA) have announced the establishment of the new NFCR Center for Molecular Imaging. This center, funded by a five-year grant from the NFCR, will be led by James P. Basilion, Ph.D., associate professor of radiology and biomedical engineering at Case Schools of Medicine and Engineering. It will focus on assisting cancer scientists to identify specific genes that are ideally suited for molecular imaging and improved diagnosis that will lead to earlier-stage treatments for cancer patients.

Research has consistently shown that the earlier a physician can diagnose a tumor, the greater the chance of effectively treating the patient against cancer and increasing the chance of survival. "Molecular imaging is being recognized as the next revolution in cancer research and is paving the way for patient-specific imaging evaluation based on molecular and genetic markers” said Dr. Basilion.

Current traditional cancer-detection methods such as magnetic resonance imaging (MRI) and ultrasound are not effective for detecting small, newly formed tumors in patients. At the new center, scientists will develop methods that will more accurately predict how a patient will respond to certain chemotherapy drugs based on the diagnosis. These methods check the production level of a group of cancer-related genes inside the patient's body and help doctors to determine more accurately what therapy should be given.



Related Links:
Case Western Reserve University School of Medicine
National Foundation for Cancer Research

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.